vaccines, including malaria and the novel coronavirus, in its upcoming unit in Odisha.Attending a virtual meeting with state chief secretary Asit Tripathy on Friday, BBIL Chairman and Managing Director Dr.
Krishna Ella said, "The company has taken up the development and production of new or improved vaccines against severe Rotavirus Diarrhoea, Malaria, Japanese Encephalitis, Rabies, Pandemic Influenza, and drug-resistant Staphylococcus aureus."Presenting BBIL's preparedness, Dr.
Ella said that the best of technology will be put in the Odisha unit.Total investment to be around ₹300 cr"It's a unit at Andharua of Bhubaneswar which would produce ten types of vaccines including malaria and COVID-19 vaccine.